Loading clinical trials...
Loading clinical trials...
Efficacy and Safety of HCP1102 in Patients With Perennial Allergic Rhinitis : A Randomized, Double-blind, Active-controlled, Multicenter Phase 3 Clinical Trial
Conditions
Interventions
HCP1102
HGP1408
Locations
1
South Korea
Gangnam Severance Hospital.
Seoul, South Korea
Start Date
October 23, 2018
Primary Completion Date
June 24, 2019
Completion Date
June 24, 2019
Last Updated
March 27, 2020
NCT01425632
NCT05299086
NCT00732368
NCT04874714
NCT04234451
NCT03655210
Lead Sponsor
Hanmi Pharmaceutical Company Limited
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions